ST Pharm Co.Ltd (237690) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.036x

Based on the latest financial reports, ST Pharm Co.Ltd (237690) has a cash flow conversion efficiency ratio of -0.036x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-21.16 Billion ≈ $-14.34 Million USD) by net assets (₩593.00 Billion ≈ $401.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ST Pharm Co.Ltd (237690) defensive interval to measure how many days the company can operate on defensive assets alone.

ST Pharm Co.Ltd - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how ST Pharm Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ST Pharm Co.Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ST Pharm Co.Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
EFORT Intelligent Equipment Co Ltd SHG:688165	-0.078x
TECNOGLASS INC. DL-0001 F:7FH	0.043x
Fulltech Fiber Glass TWO:1815	0.023x
Stanmore Resources Ltd AU:SMR	0.133x
EverCommerce Inc NASDAQ:EVCM	0.045x
China National Accord Medicines Corp Ltd SHE:000028	-0.020x
Target Hospitality Corp NASDAQ:TH	0.019x
Premier Investments Ltd AU:PMV	0.041x

Annual Cash Flow Conversion Efficiency for ST Pharm Co.Ltd (2015–2025)

The table below shows the annual cash flow conversion efficiency of ST Pharm Co.Ltd from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of ST Pharm Co.Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩593.00 Billion ≈ $401.87 Million	₩13.99 Billion ≈ $9.48 Million	0.024x	-89.16%
2024-12-31	₩502.99 Billion ≈ $340.87 Million	₩109.45 Billion ≈ $74.17 Million	0.218x	+6384.31%
2023-12-31	₩386.91 Billion ≈ $262.20 Million	₩1.30 Billion ≈ $879.90K	0.003x	-83.89%
2022-12-31	₩337.63 Billion ≈ $228.81 Million	₩7.03 Billion ≈ $4.76 Million	0.021x	-7.48%
2021-12-31	₩322.97 Billion ≈ $218.87 Million	₩7.27 Billion ≈ $4.93 Million	0.023x	+131.75%
2020-12-31	₩295.33 Billion ≈ $200.14 Million	₩-20.93 Billion ≈ $-14.19 Million	-0.071x	+30.09%
2019-12-31	₩300.96 Billion ≈ $203.95 Million	₩-30.52 Billion ≈ $-20.68 Million	-0.101x	-412.25%
2018-12-31	₩331.57 Billion ≈ $224.70 Million	₩10.77 Billion ≈ $7.30 Million	0.032x	-79.06%
2017-12-31	₩351.08 Billion ≈ $237.92 Million	₩54.44 Billion ≈ $36.89 Million	0.155x	-4.35%
2016-12-31	₩313.24 Billion ≈ $212.28 Million	₩50.78 Billion ≈ $34.41 Million	0.162x	-42.38%
2015-12-31	₩127.33 Billion ≈ $86.29 Million	₩35.82 Billion ≈ $24.28 Million	0.281x	--

About ST Pharm Co.Ltd

KQ:237690 Korea Pharmaceuticals

Market Cap

$1.61 Billion

₩2.37 Trillion KRW

Market Cap Rank

#7107 Global

#181 in Korea

Share Price

₩127000.00

Change (1 day)

-4.51%

52-Week Range

₩76500.00 - ₩168700.00

All Time High

₩168700.00